{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:24:31Z","timestamp":1792538671930,"version":"4.5.0"},"reference-count":169,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1080\/10673220591003605","type":"journal-article","created":{"date-parts":[[2005,9,15]],"date-time":"2005-09-15T05:09:37Z","timestamp":1126760977000},"page":"141-154","source":"Crossref","is-referenced-by-count":284,"title":["Implications of Chronic Methamphetamine Use: A Literature Review"],"prefix":"10.1097","volume":"13","author":[{"given":"Charles W.","family":"Meredith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Ang-Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Saxon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-2-20210129","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/02791072.2000.10400221","article-title":"History of the methamphetamine problem.","volume":"32","author":"Anglin M D, Burke","year":"2000","journal-title":"J Psychoactive Drugs"},{"key":"R7-2-20210129","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1176\/jnp.15.3.317","article-title":"Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review.","volume":"15","author":"Nordahl T E, Salo","year":"2003","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"R9-2-20210129","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1520\/JFS12878J","article-title":"Lithium-ammonia reduction of ephedrine to methamphetamine: an unusual clandestine synthesis.","volume":"35","author":"Ely","year":"1990","journal-title":"J Forensic Sci"},{"key":"R16-2-20210129","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/j.1360-0443.1993.tb03144.x","article-title":"E, Cottler L B, Cacciola J. Severity of dependence: data from the DSM-IV field trials.","volume":"88","author":"Woody","year":"1993","journal-title":"Addiction"},{"key":"R21-2-20210129","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00006565-199812000-00001","article-title":"Inadvertent methamphetamine poisoning inpediatric patients.","volume":"14","author":"Kolecki","year":"1998","journal-title":"Pediatr Emerg Care"},{"key":"R23-2-20210129","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1651-2227.1978.tb16283.x","article-title":"The influence of amphetamine addiction on pregnancy and the newborn infant.","volume":"67","author":"Eriksson","year":"1978","journal-title":"Acta Paediatr Scand"},{"key":"R24-2-20210129","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/00016348109158127","article-title":"Amphetamine addiction and pregnancy. II. Pregnancy, delivery and the neonatal period. Socio-medical aspects.","volume":"60","author":"Eriksson","year":"1981","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R25-2-20210129","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0022-3476(89)80661-4","article-title":"Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: incidence and clinical correlates.","volume":"115","author":"Dixon S D, Bejar","year":"1989","journal-title":"J Pediatr"},{"key":"R26-2-20210129","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0889-8545(05)70361-2","article-title":"Prenatal exposure to amphetamines. Risks and adverse outcomes in pregnancy.","volume":"25","year":"1998","journal-title":"Obstet Gynecol Clin North Am"},{"key":"R27-2-20210129","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00004703-200302000-00006","article-title":"Effects of prenatal methamphetamine exposure on fetal growth and drug withdrawal symptoms in infants born at term.","volume":"24","author":"Smith","year":"2003","journal-title":"J Dev Behav Pediatr"},{"key":"R28-2-20210129","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1469-8749.1993.tb11731.x","article-title":"L, Struthers J M, Gospe S M Jr. Visual evoked potentials and visual processing in stimulant drug-exposed infants.","volume":"35","author":"Hansen","year":"1993","journal-title":"Dev Med Child Neurol"},{"key":"R29-2-20210129","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0145-2134(88)90067-1","article-title":"Predictive indicators for adjustment in 4-year-old children whose mothers used amphetamine during pregnancy.","volume":"12","author":"Billing","year":"1988","journal-title":"Child Abuse Negl"},{"key":"R30-2-20210129","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0145-2134(94)90091-4","article-title":"The influence of environmental factors on behavioural problems in 8-year-old children exposed to amphetamine during fetal life.","volume":"18","author":"Billing","year":"1994","journal-title":"Child Abuse Negl"},{"key":"R31-2-20210129","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/j.1651-2227.1989.tb11179.x","article-title":"Health and development of 8-year-old children whose mothers abused amphetamine during pregnancy.","volume":"78","author":"Eriksson","year":"1989","journal-title":"Acta Paediatr Scand"},{"key":"R32-2-20210129","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1177\/140349480002800212","article-title":"Amphetamine abuse during pregnancy: environmental factors and outcome after 14-15 years.","volume":"28","author":"Eriksson","year":"2000","journal-title":"Scand J Public Health"},{"key":"R33-2-20210129","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1651-2227.1985.tb10946.x","article-title":"Pre-school children of amphetamine-addicted mothers. I. Somatic and psychomotor development.","volume":"74","author":"Billing","year":"1985","journal-title":"Acta Paediatr Scand"},{"key":"R34-2-20210129","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1651-2227.1994.tb13380.x","article-title":"Amphetamine addiction during pregnancy: 10-year follow-up.","volume":"404","author":"Eriksson","year":"1994","journal-title":"Acta Paediatr Suppl"},{"key":"R35-2-20210129","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pscychresns.2004.06.004","article-title":"Smaller subcortical volumes and cognitive deficits in children with prenatal methamphetamine exposure.","volume":"132","author":"Chang","year":"2004","journal-title":"Psychiatry Res"},{"key":"R36-2-20210129","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00042560-200111010-00010","article-title":"N, Kral A H, Gee L, et al. Trends in HIV seroprevalence and risk among gay and bisexual men who inject drugs in San Francisco, 1988 to 2000.","volume":"28","author":"Bluthenthal","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R37-2-20210129","first-page":"1275","article-title":"V, Thiede H, McGough J P, Gordon D. Risk factors for HIV infection among injection drug users: results of blinded surveys in drug treatment centers, King County, Washington 1988-1991.","volume":"6","author":"Harris","year":"1993","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R38-2-20210129","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1300\/J082v41n02_02","article-title":"N, Parsons J T, Stirratt M J. A double epidemic: crystal methamphetamine drug use in relation to HIV transmission among gay men.","volume":"41","author":"Halkitis","year":"2001","journal-title":"J Homosex"},{"key":"R39-2-20210129","first-page":"11","article-title":"Sexual risk for HIV transmission among gaybisexual men in substance-abuse treatment.","volume":"5","author":"Paul J P, Stall","year":"1993","journal-title":"AIDS Educ Prev"},{"key":"R40-2-20210129","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0740-5472(96)00098-0","article-title":"A, Ling W., Sexual H IV. risk among gay and bisexual male methamphetamine abusers.","volume":"13","author":"Frosch","year":"1996","journal-title":"J Subst Abuse Treat"},{"key":"R41-2-20210129","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1300\/J069v21n01_08","article-title":"J, Freese T E. Patient characteristics, HIV serostatus, and risk behaviors among gay and bisexual males seeking treatment for methamphetamine abuse and dependence in Los Angeles.","volume":"21","author":"Shoptaw","year":"2002","journal-title":"J Addict Dis"},{"key":"R42-2-20210129","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0193-953X(18)30723-8","article-title":"CNS stimulants and the look-alike drugs.","volume":"7","year":"1984","journal-title":"Psychiatr Clin North Am"},{"key":"R43-2-20210129","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/379606a0","article-title":"R, Wightman R M, Caron M G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter.","volume":"379","author":"Giros","year":"1996","journal-title":"Nature"},{"key":"R44-2-20210129","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1523\/JNEUROSCI.18-13-04861.1998","article-title":"R, Valenzano K J, Caron M G. Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter.","volume":"18","author":"Fumagalli","year":"1998","journal-title":"J Neurosci"},{"key":"R45-2-20210129","first-page":"21","article-title":"Patterns of methamphetamine abuse and their consequences.","volume":"21","year":"2002","journal-title":"J Addict Dis"},{"key":"R46-2-20210129","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1300\/J069v21n01_09","article-title":"Status of methamphetamine users 2-5 years after outpatient treatment.","volume":"21","author":"Rawson R A, Huber","year":"2002","journal-title":"J Addict Dis"},{"key":"R47-2-20210129","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/1098-2396(200102)39:2<161::AID-SYN7>3.0.CO;2-E","article-title":"K, Melega W P, Kuczenski R, Segal D S. Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse.","volume":"39","author":"Cho","year":"2001","journal-title":"Synapse"},{"key":"R48-2-20210129","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/02791072.2000.10400234","article-title":"Methamphetamine and cocaine users: differences in characteristics and treatment retention.","volume":"32","author":"Rawson","year":"2000","journal-title":"J Psychoactive Drugs"},{"key":"R49-2-20210129","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM198805053181806","article-title":"Cocaine and other stimulants. Actions, abuse, and treatment.","volume":"318","year":"1988","journal-title":"N Engl J Med"},{"key":"R51-2-20210129","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0740-5472(03)00028-X","article-title":"V, Huber D L, Block R I, Hall J A. Treatment of methamphetamine abuse: research findings and clinical directions.","volume":"24","author":"Cretzmeyer","year":"2003","journal-title":"J Subst Abuse Treat"},{"key":"R52-2-20210129","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0376-8716(97)00160-9","article-title":"J. Self detoxication by amphetamine dependent patients: a pilot study.","volume":"49","author":"Cantwell","year":"1998","journal-title":"Drug Alcohol Depend"},{"key":"R53-2-20210129","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/10550490490459915","article-title":"Methamphetamine abstinence syndrome: preliminary findings.","volume":"13","author":"Newton","year":"2004","journal-title":"Am J Addict"},{"key":"R55-2-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0173(01)00054-6","article-title":"J, Lee T H, Ellinwood E H. Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment.","volume":"36","author":"Davidson","year":"2001","journal-title":"Brain Res Brain Res Rev"},{"key":"R56-2-20210129","first-page":"257","article-title":"Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain.","volume":"214","year":"1980","journal-title":"J Pharmacol Exp Ther"},{"key":"R57-2-20210129","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0006-8993(80)90952-X","article-title":"A, Schuster C R, Seiden L S. Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study.","volume":"193","author":"Ricaurte","year":"1980","journal-title":"Brain Res"},{"key":"R58-2-20210129","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0006-8993(82)90198-6","article-title":"A, Guillery R W, Seiden L S, Schuster C R, Moore R Y. Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain.","volume":"235","author":"Ricaurte","year":"1982","journal-title":"Brain Res"},{"key":"R59-2-20210129","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0006-8993(84)91221-6","article-title":"A, Seiden L S, Schuster C R. Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers.","volume":"303","author":"Ricaurte","year":"1984","journal-title":"Brain Res"},{"key":"R60-2-20210129","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0006-8993(90)90955-B","article-title":"J, Linder J C, Martone M E, Groves P M. Histological and ultrastructural evidence that D-amphetamine causes degeneration in neostriatum and frontal cortex of rats.","volume":"518","author":"Ryan","year":"1990","journal-title":"Brain Res"},{"key":"R61-2-20210129","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1212\/WNL.30.5.547","article-title":"C, Ricaurte G A, Johanson C E, Schuster C R, Seiden L S. Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate.","volume":"30","author":"Wagner","year":"1980","journal-title":"Neurology"},{"key":"R62-2-20210129","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0006-8993(80)91265-2","article-title":"C, Ricaurte G A, Seiden L S, Schuster C R, Miller R J, Westley J. Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine.","volume":"181","author":"Wagner","year":"1980","journal-title":"Brain Res"},{"key":"R63-2-20210129","first-page":"42","article-title":"Adrenal and striatal tyrosine hydroxylase activity after methamphetamine.","volume":"185","year":"1973","journal-title":"J Pharmacol Exp Ther"},{"key":"R64-2-20210129","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/BF00964403","article-title":"Role of the serotonin uptake carrier in the neurochemical response to methamphetamine: effects of citalopram and chlorimipramine.","volume":"10","year":"1985","journal-title":"Neurochem Res"},{"key":"R65-2-20210129","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0376-8716(82)90067-9","article-title":"C, Preston K, Ricaurte G A, Schuster C R, Seiden L S. Neurochemical similarities between d,l-cathinone and d-amphetamine.","volume":"9","author":"Wagner","year":"1982","journal-title":"Drug Alcohol Depend"},{"key":"R66-2-20210129","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0014-2999(97)01152-7","article-title":"Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine.","volume":"334","author":"Frey","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"R67-2-20210129","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0006-8993(00)02439-2","article-title":"C, Lacan G, Tanious S P, Melega W P. Recovery from methamphetamine induced long-term nigrostriatal dopaminergic deficits without substantia nigra cell loss.","volume":"871","author":"Harvey","year":"2000","journal-title":"Brain Res"},{"key":"R68-2-20210129","doi-asserted-by":"crossref","first-page":"7653","DOI":"10.1523\/JNEUROSCI.19-17-07653.1999","article-title":"Recovery of presynaptic dopaminergic functioning in rats treated with neurotoxic doses of methamphetamine.","volume":"19","year":"1999","journal-title":"J Neurosci"},{"key":"R69-2-20210129","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1046\/j.1471-4159.2000.0741079.x","article-title":"Attenuation and recovery of evoked overflow of striatal serotonin in rats treated with neurotoxic doses of methamphetamine.","volume":"74","year":"2000","journal-title":"J Neurochem"},{"key":"R70-2-20210129","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0091-3057(98)00066-5","article-title":"D, Castaneda E, Hodge G K. Long-term monoamine depletion, differential recovery, and subtle behavioral impairment following methamphetamine-induced neurotoxicity.","volume":"61","author":"Friedman","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"R71-2-20210129","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/(SICI)1098-2396(199601)22:1<63::AID-SYN7>3.0.CO;2-G","article-title":"P, Quintana J, Raleigh M J, et al. 6-18Ffluoro-L-DOPA-PET studies show partial reversibility of long-term effects of chronic amphetamine in monkeys.","volume":"22","author":"Melega","year":"1996","journal-title":"Synapse"},{"key":"R72-2-20210129","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0166-4328(97)83333-5","article-title":"P, Raleigh M J, Stout D B, Huang S C, Phelps M E. Ethological and 6-18Ffluoro-L-DOPA-PET profiles of long-term vulnerability to chronic amphetamine.","volume":"84","author":"Melega","year":"1997","journal-title":"Behav Brain Res"},{"key":"R73-2-20210129","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0006-8993(89)91279-1","article-title":"L, Ricaurte G A, Forno L S, Seiden L S. Long-term effects of chronic methamphetamine administration in rhesus monkeys.","volume":"486","author":"Woolverton","year":"1989","journal-title":"Brain Res"},{"key":"R75-2-20210129","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1300\/J069v21n01_04","article-title":"A comparison of patterns of methamphetamine and cocaine use.","volume":"21","author":"Simon S L, Richardson","year":"2002","journal-title":"J Addict Dis"},{"key":"R76-2-20210129","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1523\/JNEUROSCI.18-01-00419.1998","article-title":"Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: evidence from 11CWIN-35,428 positron emission tomography studies and direct in vitro determinations.","volume":"18","author":"Villemagne","year":"1998","journal-title":"J Neurosci"},{"key":"R77-2-20210129","doi-asserted-by":"crossref","first-page":"8417","DOI":"10.1523\/JNEUROSCI.18-20-08417.1998","article-title":"D, Wong D F, Yokoi F, Villemagne V, Dannals R F, Ricaurte G A. Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with 11CWIN-35,428.","volume":"18","author":"McCann","year":"1998","journal-title":"J Neurosci"},{"key":"R78-2-20210129","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nm0696-699","article-title":"M, Kalasinsky K S, Levey A I, et al. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users.","volume":"2","author":"Wilson","year":"1996","journal-title":"Nat Med"},{"key":"R79-2-20210129","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/brain\/awh046","article-title":"Why is parkinsonism not a feature of human methamphetamine users?","volume":"127","author":"Moszczynska","year":"2004","journal-title":"Brain"},{"key":"R80-2-20210129","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF00500283","article-title":"Influence of dopamine synthesis on methamphetamine-induced changes in striatal and adrenal tyrosine hydroxylase activity.","volume":"310","year":"1979","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R81-2-20210129","first-page":"539","article-title":"J, Ritter J K, Sonsalla P K, Hanson G R, Gibb J W. Role of dopamine in the neurotoxic effects of methamphetamine.","volume":"233","author":"Schmidt","year":"1985","journal-title":"J Pharmacol Exp Ther"},{"key":"R82-2-20210129","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0014-2999(87)90616-9","article-title":"M, Hanson G R, Gibb J W. Role of the dopaminergic nigrostriatal pathway in methamphetamine-induced depression of the neostriatal serotonergic system.","volume":"135","author":"Johnson","year":"1987","journal-title":"Eur J Pharmacol"},{"key":"R83-2-20210129","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0006-8993(90)90606-C","article-title":"J, Commins D L, Vosmer G, Seiden L S. alpha-Methyl-p-tyrosine pretreatment partially prevents methamphetamine-induced endogenous neurotoxin formation.","volume":"515","author":"Axt","year":"1990","journal-title":"Brain Res"},{"key":"R84-2-20210129","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0091-3057(84)90125-4","article-title":"Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methylamphetamine.","volume":"21","author":"Seiden L S, Vosmer","year":"1984","journal-title":"Pharmacol Biochem Behav"},{"key":"R85-2-20210129","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1046\/j.1471-4159.1994.62010380.x","article-title":"Attenuation of methamphetamine-induced neurotoxicity in copperzinc superoxide dismutase transgenic mice.","volume":"62","author":"Cadet J L, Sheng","year":"1994","journal-title":"J Neurochem"},{"key":"R86-2-20210129","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/0028-3908(89)90130-5","article-title":"Methamphetamine-induced neuronal damage: a possible role for free radicals.","volume":"28","year":"1989","journal-title":"Neuropharmacology"},{"key":"R87-2-20210129","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0006-8993(95)01502-7","article-title":"Autoradiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain: attenuation in CuZn-superoxide dismutase transgenic mice.","volume":"714","author":"Hirata","year":"1996","journal-title":"Brain Res"},{"key":"R88-2-20210129","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0006-8993(00)02707-4","article-title":"Methamphetamine toxicity is attenuated in mice that overexpress human manganese superoxide dismutase.","volume":"878","author":"Maragos W F, Jakel","year":"2000","journal-title":"Brain Res"},{"key":"R89-2-20210129","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1046\/j.1471-4159.1996.67041770.x","article-title":"F. The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo.","volume":"67","author":"Itzhak","year":"1996","journal-title":"J Neurochem"},{"key":"R90-2-20210129","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0028-3908(98)00067-7","article-title":"L, Black M D, Ali S F. Effect of melatonin on methamphetamine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity and methamphetamine-induced behavioral sensitization.","volume":"37","author":"Itzhak","year":"1998","journal-title":"Neuropharmacology"},{"key":"R91-2-20210129","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0028-3908(86)90184-X","article-title":"C, Carelli R M, Jarvis M F. Ascorbic acid reduces the dopamine depletion induced by methamphetamine and the 1-methyl-4-phenyl pyridinium ion.","volume":"25","author":"Wagner","year":"1986","journal-title":"Neuropharmacology"},{"key":"R92-2-20210129","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1073\/pnas.93.5.1956","article-title":"G, Lewis D A, Zigmond M J. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections.","volume":"93","author":"Hastings","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R94-2-20210129","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJM198909283211321","article-title":"The hazards of smokable methamphetamine.","volume":"321","year":"1989","journal-title":"N Engl J Med"},{"key":"R95-2-20210129","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1520\/JFS14464J","article-title":"B, Stephens B G, Ho C H. Methamphetamine-related deaths in San Francisco: demographic, pathologic, and toxicologic profiles.","volume":"44","author":"Karch","year":"1999","journal-title":"J Forensic Sci"},{"key":"R96-2-20210129","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1520\/JFS14408J","article-title":"Human methamphetamine-related fatalities in Taiwan during 1991-1996.","volume":"44","year":"1999","journal-title":"J Forensic Sci"},{"key":"R97-2-20210129","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1520\/JFS14407J","article-title":"Methamphetamine as a risk factor for acute aortic dissection.","volume":"44","year":"1999","journal-title":"J Forensic Sci"},{"key":"R99-2-20210129","first-page":"198","article-title":"R, Bretz S W, Johnson E B, Turnipseed S D, Brofeldt B T, Derlet R W. Methamphetamine abuse and emergency department utilization.","volume":"170","author":"Richards","year":"1999","journal-title":"West J Med"},{"key":"R100-2-20210129","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1212\/WNL.39.8.1037","article-title":"K, Lowenstein D H, Simon R P. Seizures associated with recreational drug abuse.","volume":"39","author":"Alldredge","year":"1989","journal-title":"Neurology"},{"key":"R101-2-20210129","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/0735-6757(93)90001-R","article-title":"R, Kearney T E, Dyer J E, Benowitz N L, Blanc P D. Seizures associated with poisoning and drug overdose.","volume":"11","author":"Olson","year":"1993","journal-title":"Am J Emerg Med"},{"key":"R102-2-20210129","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1520\/JFS13935J","article-title":"Methamphetamine and driving impairment.","volume":"41","year":"1996","journal-title":"J Forensic Sci"},{"key":"R103-2-20210129","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev.ne.09.030186.002041","article-title":"E, De Long M R, Strick P L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex.","volume":"9","author":"Alexander","year":"1986","journal-title":"Annu Rev Neurosci"},{"key":"R104-2-20210129","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1212\/WNL.47.3.718","article-title":"M, Levey A I, Rajput A, et al. Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinsons disease.","volume":"47","author":"Wilson","year":"1996","journal-title":"Neurology"},{"key":"R105-2-20210129","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJM198804073181402","article-title":"Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinsons disease. Pathophysiologic and clinical implications.","volume":"318","author":"Kish S J, Shannak","year":"1988","journal-title":"N Engl J Med"},{"key":"R106-2-20210129","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00005053-196704000-00005","article-title":"Amphetamine psychosis. I. Description of the individuals and the process.","volume":"144","author":"Ellinwood","year":"1967","journal-title":"J Nerv Ment Dis"},{"key":"R107-2-20210129","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/10550490490512834","article-title":"Quantitative drug levels in stimulant psychosis: relationship to symptom severity, catecholamines and hyperkinesia.","volume":"13","author":"Batki S L, Harris","year":"2004","journal-title":"Am J Addict"},{"key":"R108-2-20210129","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1520\/JFS12651J","article-title":"Cocaine- and methamphetamine-related deaths in San Diego County (1987): homicides and accidental overdoses.","volume":"34","year":"1989","journal-title":"J Forensic Sci"},{"key":"R110-2-20210129","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0379-0738(96)02095-6","article-title":"Amphetamine derivative related deaths.","volume":"85","author":"Lora-Tamayo","year":"1997","journal-title":"Forensic Sci Int"},{"key":"R111-2-20210129","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1520\/JFS16085J","article-title":"K, Fligner C L, Haddix T. Cause and manner of death in fatalities involving methamphetamine.","volume":"43","author":"Logan","year":"1998","journal-title":"J Forensic Sci"},{"key":"R112-2-20210129","first-page":"1","article-title":"Methamphetamine and opiate-related fatalities in Taiwan Forensic Medicine Center in 1996.","volume":"2","author":"Shaw","year":"1997","journal-title":"Narc Bull (Taiwan)"},{"key":"R113-2-20210129","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1176\/ajp.156.4.662","article-title":"Chronic psychotic illness from methamphetamine.","volume":"156","author":"Buffenstein","year":"1999","journal-title":"Am J Psychiatry"},{"key":"R114-2-20210129","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1176\/appi.ajp.158.8.1206","article-title":"Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET.","volume":"158","author":"Sekine","year":"2001","journal-title":"Am J Psychiatry"},{"key":"R115-2-20210129","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/10550490490436055","article-title":"E, Cohen J B, Christian D, et al. Psychiatric symptoms in methamphetamine users.","volume":"13","author":"Zweben","year":"2004","journal-title":"Am J Addict"},{"key":"R116-2-20210129","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1001\/archpsyc.61.1.73","article-title":"D, Simon S L, Berman S M, et al. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers.","volume":"61","author":"London","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"R117-2-20210129","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1176\/jnp.12.4.480","article-title":"D, Newton T F, Longshore D, Anglin M D, van Gorp W G, Gawin F H. Psychiatric comorbidity of methamphetamine dependence in a forensic sample.","volume":"12","author":"Kalechstein","year":"2000","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"R118-2-20210129","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1080\/10550490050148053","article-title":"Cognitive impairment in individuals currently using methamphetamine.","volume":"9","author":"Simon S L, Domier","year":"2000","journal-title":"Am J Addict"},{"key":"R119-2-20210129","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1176\/appi.ajp.158.3.377","article-title":"D, Chang L, Wang G J, et al. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.","volume":"158","author":"Volkow","year":"2001","journal-title":"Am J Psychiatry"},{"key":"R120-2-20210129","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1176\/jnp.15.2.215","article-title":"D, Newton T F, Green M. Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence.","volume":"15","author":"Kalechstein","year":"2003","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"R121-2-20210129","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1196\/annals.1316.036","article-title":"Neuromechanism of developing methamphetamine psychosis: a neuroimaging study.","volume":"1025","author":"Iyo","year":"2004","journal-title":"Ann NY Acad Sci"},{"key":"R122-2-20210129","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0165-0173(94)90012-4","article-title":"Stimulant-induced psychosis, the dopamine theory of schizophrenia, and the habenula.","volume":"19","author":"Ellison","year":"1994","journal-title":"Brain Res Brain Res Rev"},{"key":"R124-2-20210129","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/10550490050172209","article-title":"L. Stimulant psychosis: symptom profile and acute clinical course.","volume":"9","author":"Harris","year":"2000","journal-title":"Am J Addict"},{"key":"R125-2-20210129","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1017\/S0033291703008353","article-title":"K, Lin S K, Sham P C, et al. Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis.","volume":"33","author":"Chen","year":"2003","journal-title":"Psychol Med"},{"key":"R126-2-20210129","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/sj.tpj.6500189","article-title":"Nine- or fewer repeat alleles in VNTR polymorphism of the dopamine transporter gene is a strong risk factor for prolonged methamphetamine psychosis.","volume":"3","author":"Ujike","year":"2003","journal-title":"Pharmacogenomics J"},{"key":"R127-2-20210129","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/ajmg.b.20148","article-title":"Association between the glutathione S-transferase M1 gene deletion and female methamphetamine abusers.","volume":"126B","author":"Koizumi","year":"2004","journal-title":"Am J Med Genet"},{"key":"R128-2-20210129","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1196\/annals.1316.040","article-title":"Study of association between alpha-synuclein gene polymorphism and methamphetamine psychosisdependence.","volume":"1025","author":"Kobayashi","year":"2004","journal-title":"Ann NY Acad Sci"},{"key":"R129-2-20210129","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1176\/jnp.14.2.239-a","article-title":"Risk factors for treatment-resistive methamphetamine psychosis.","volume":"14","author":"Fujii","year":"2002","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"R130-2-20210129","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s004060050073","article-title":"Spontaneous recurrence of methampetamine psychosis: increased sensitivity to stress associated with noradrenergic hyperactivity and dopaminergic change.","volume":"249","author":"Yui","year":"1999","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"R131-2-20210129","first-page":"429","article-title":"Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis.","volume":"18","author":"Sato","year":"1983","journal-title":"Biol Psychiatry"},{"key":"R132-2-20210129","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1176\/ajp.154.8.1170a","article-title":"Risperidone treatment of methamphetamine psychosis.","volume":"154","author":"Misra","year":"1997","journal-title":"Am J Psychiatry"},{"key":"R133-2-20210129","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00004714-200006000-00023","article-title":"K, Kofoed L, Oesterheld J R, Richards G A. Olanzapine treatment of methamphetamine psychosis.","volume":"20","author":"Misra","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"R135-2-20210129","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1192\/bjp.176.3.285","article-title":"Psychiatric symptoms among clients seeking treatment for drug dependence. Intake data from the National Treatment Outcome Research Study.","volume":"176","author":"Marsden","year":"2000","journal-title":"Br J Psychiatry"},{"key":"R136-2-20210129","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1300\/J069v21n01_07","article-title":"L, Domier C P, Richardson K, Rawson R A, Ling W. Cognitive deficits among methamphetamine users with attention deficit hyperactivity disorder symptomatology.","volume":"21","author":"Sim","year":"2002","journal-title":"J Addict Dis"},{"key":"R138-2-20210129","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1081\/ADA-100101871","article-title":"T, Saladin M E, Johnson D, Waid R, Rittenbury M. Attention-deficithyperactivity disorder and substance use: symptom pattern and drug choice.","volume":"25","author":"Clure","year":"1999","journal-title":"Am J Drug Alcohol Abuse"},{"key":"R140-2-20210129","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1176\/ajp.153.9.1143","article-title":"Age-dependent decline of attention deficit hyperactivity disorder.","volume":"153","year":"1996","journal-title":"Am J Psychiatry"},{"key":"R141-2-20210129","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0006-3223(00)00889-1","article-title":"Attention-deficithyperactivity disorder in adults: an overview.","volume":"48","author":"Faraone S V, Biederman","year":"2000","journal-title":"Biol Psychiatry"},{"key":"R142-2-20210129","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1176\/appi.ajp.157.5.816","article-title":"Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type.","volume":"157","author":"Biederman","year":"2000","journal-title":"Am J Psychiatry"},{"key":"R143-2-20210129","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0079-6123(00)26028-7","article-title":"D, Roth R H, Taylor J R. Role for dopamine in the behavioral functions of the prefrontal corticostriatal system: implications for mental disorders and psychotropic drug action.","volume":"126","author":"Jentsch","year":"2000","journal-title":"Prog Brain Res"},{"key":"R144-2-20210129","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/brcg.1999.1129","article-title":"Dopamine and the origins of human intelligence.","volume":"41","year":"1999","journal-title":"Brain Cogn"},{"key":"R145-2-20210129","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF00916547","article-title":"A, Grodzinsky G, Du Paul G J. Frontal lobe functions in attention deficit disorder with and without hyperactivity: a review and research report.","volume":"20","author":"Barkley","year":"1992","journal-title":"J Abnorm Child Psychol"},{"key":"R146-2-20210129","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0387-7604(02)00152-3","article-title":"Issues in the diagnosis of attention-deficithyperactivity disorder in children.","volume":"25","year":"2003","journal-title":"Brain Dev"},{"key":"R147-2-20210129","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0006-3223(97)00392-2","article-title":"J, Biederman J, Weber W, Hatch M, Faraone S V. Neuropsychological function in adults with attention-deficit hyperactivity disorder.","volume":"44","author":"Seidman","year":"1998","journal-title":"Biol Psychiatry"},{"key":"R148-2-20210129","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1017\/S0033291799008338","article-title":"Executive function and attention deficit hyperactivity disorder: stimulant medication and better executive function performance in children.","volume":"29","author":"Kempton","year":"1999","journal-title":"Psychol Med"},{"key":"R149-2-20210129","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/archpsyc.58.8.775","article-title":"Efficacy of a mixed amphetamine salts compound in adults with attention-deficithyperactivity disorder.","volume":"58","author":"Spencer","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"R150-2-20210129","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1176\/appi.ajp.158.2.282","article-title":"E, Spencer T J, Biederman J, et al. A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults.","volume":"158","author":"Wilens","year":"2001","journal-title":"Am J Psychiatry"},{"key":"R151-2-20210129","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1542\/peds.111.1.179","article-title":"E, Faraone S V, Biederman J, Gunawardene S. Does stimulant therapy of attention-deficithyperactivity disorder beget later substance abuse? A meta-analytic review of the literature.","volume":"111","author":"Wilens","year":"2003","journal-title":"Pediatrics"},{"key":"R152-2-20210129","first-page":"885","article-title":"F, Wender P H, Rieimherr F W. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit disorder.","volume":"150","author":"Ward","year":"1993","journal-title":"Am J Psychiatry"},{"key":"R153-2-20210129","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF00428024","article-title":"C, Tinklenberg J R, Roth W T, Kopell B S. Methamphetamine and diphenhydramine effects on the rate of cognitive processing.","volume":"59","author":"Mohs","year":"1978","journal-title":"Psychopharmacology"},{"key":"R154-2-20210129","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1037\/h0048652","article-title":"The effect of caffeine and alcohol on simple visual reaction time.","volume":"52","year":"1959","journal-title":"J Comp Physiol Psychol"},{"key":"R155-2-20210129","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF02246156","article-title":"Effect of amphetamine on long-term retention of verbal material.","volume":"119","author":"Soetens","year":"1995","journal-title":"Psychopharmacology"},{"key":"R156-2-20210129","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0376-8716(97)00132-4","article-title":"P. Attention and memory in illicit amphetamine users.","volume":"48","author":"McKetin","year":"1997","journal-title":"Drug Alcohol Depend"},{"key":"R157-2-20210129","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0376-8716(98)00022-2","article-title":"P. Attention and memory in illicit amphetamine users: comparison with non-drug-using controls.","volume":"50","author":"McKetin","year":"1998","journal-title":"Drug Alcohol Depend"},{"key":"R158-2-20210129","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1300\/J069v21n01_06","article-title":"L, Domier C P, Sim T, Richardson K, Rawson R A, Ling W. Cognitive performance of current methamphetamine and cocaine abusers.","volume":"21","author":"Simon","year":"2002","journal-title":"J Addict Dis"},{"key":"R159-2-20210129","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0893-133X(00)00097-X","article-title":"J, Iddon J L, Baldacchino A M, et al. Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers.","volume":"23","author":"Ornstein","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"R160-2-20210129","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0165-1781(02)00111-7","article-title":"Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals.","volume":"111","author":"Salo","year":"2002","journal-title":"Psychiatry Res"},{"key":"R161-2-20210129","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jsat.2004.03.011","article-title":"The effect of relapse on cognition in abstinent methamphetamine abusers.","volume":"27","author":"Simon S L, Dacey","year":"2004","journal-title":"J Subst Abuse Treat"},{"key":"R162-2-20210129","doi-asserted-by":"crossref","first-page":"9414","DOI":"10.1523\/JNEUROSCI.21-23-09414.2001","article-title":"D, Chang L, Wang G J, et al. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence.","volume":"21","author":"Volkow","year":"2001","journal-title":"J Neurosci"},{"key":"R163-2-20210129","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0925-4927(02)00004-5","article-title":"Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users.","volume":"114","author":"Chang","year":"2002","journal-title":"Psychiatry Res"},{"key":"R164-2-20210129","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0376-8716(01)00197-1","article-title":"Neuropsychological performance of individuals dependent on crack-cocaine, or crack-cocaine and alcohol, at 6 weeks and 6 months of abstinence.","volume":"66","author":"Di Sclafani","year":"2002","journal-title":"Drug Alcohol Depend"},{"key":"R165-2-20210129","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0376-8716(94)01072-S","article-title":"W, Katzung V M, Moreland V J, Nixon S J. Neuropsychological performance of recently abstinent alcoholics and cocaine abusers.","volume":"37","author":"Beatty","year":"1995","journal-title":"Drug Alcohol Depend"},{"key":"R166-2-20210129","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0376-8716(93)90087-7","article-title":"G, Herzberg D S, et al. Neuropsychological deficits in abstinent cocaine abusers: preliminary findings after two weeks of abstinence.","volume":"32","author":"Berry","year":"1993","journal-title":"Drug Alcohol Depend"},{"key":"R167-2-20210129","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0376-8716(98)00002-7","article-title":"Neuropsychological functioning in drug abusers.","volume":"50","year":"1998","journal-title":"Drug Alcohol Depend"},{"key":"R168-2-20210129","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1046\/j.1471-4159.2002.00820.x","article-title":"C, Pablo J, Ouyang Q, Hearn W L, Izenwasser S. Dopamine transport function is elevated in cocaine users.","volume":"81","author":"Mash","year":"2002","journal-title":"J Neurochem"},{"key":"R169-2-20210129","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1176\/ajp.156.2.238","article-title":"Y, Zhang L, Desmond T, Frey K A, Dalack G W, Cassin B J. Striatal dopaminergic abnormalities in human cocaine users.","volume":"156","author":"Little","year":"1999","journal-title":"Am J Psychiatry"},{"key":"R170-2-20210129","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/BF02246266","article-title":"T, Best S E, Wallace E A, et al. Euphorigenic doses of cocaine reduce 123Ibeta-CIT SPECT measures of dopamine transporter availability in human cocaine addicts.","volume":"122","author":"Malison","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"R171-2-20210129","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1176\/ajp.155.6.832","article-title":"T, Best S E, van Dyck C H, et al. Elevated striatal dopamine transporters during acute cocaine abstinence as measured by 123I beta-CIT SPECT.","volume":"155","author":"Malison","year":"1998","journal-title":"Am J Psychiatry"},{"key":"R172-2-20210129","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s002210000386","article-title":"C, Lacan G, Melegan W P. Regional heterogeneity of dopaminergic deficits in vervet monkey striatum and substantia nigra after methamphetamine exposure.","volume":"133","author":"Harvey","year":"2000","journal-title":"Exp Brain Res"},{"key":"R173-2-20210129","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1176\/appi.ajp.157.2.290","article-title":"Prediction of detached personality in healthy subjects by low dopamine transporter binding.","volume":"157","author":"Laakso","year":"2000","journal-title":"Am J Psychiatry"},{"key":"R174-2-20210129","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1176\/ajp.156.1.19","article-title":"D, Wang G J, Fowler J S, et al. Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction.","volume":"156","author":"Volkow","year":"1999","journal-title":"Am J Psychiatry"},{"key":"R175-2-20210129","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1212\/WNL.54.6.1344","article-title":"Evidence for long-term neurotoxicity associated with methamphetamine abuse: a 1H MRS study.","volume":"54","author":"Ernst","year":"2000","journal-title":"Neurology"},{"key":"R176-2-20210129","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0893-133X(02)00321-4","article-title":"Metabolite alterations in basal ganglia associated with methamphetamine-related psychiatric symptoms. A proton MRS study.","volume":"27","author":"Sekine","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"R177-2-20210129","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0925-4927(02)00088-4","article-title":"Low N-acetyl-aspartate and high choline in the anterior cingulum of recently abstinent methamphetamine-dependent subjects: a preliminary proton MRS study. Magnetic resonance spectroscopy.","volume":"116","author":"Nordahl T E, Salo","year":"2002","journal-title":"Psychiatry Res"},{"key":"R178-2-20210129","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0893-133X(01)00334-7","article-title":"P, Hozack N E, Zauscher B E, et al. Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects.","volume":"26","author":"Paulus","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"R179-2-20210129","doi-asserted-by":"crossref","first-page":"6028","DOI":"10.1523\/JNEUROSCI.0713-04.2004","article-title":"M, Hayashi K M, Simon S L, et al. Structural abnormalities in the brains of human subjects who use methamphetamine.","volume":"24","author":"Thompson","year":"2004","journal-title":"J Neurosci"},{"key":"R180-2-20210129","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0740-5472(92)90020-O","article-title":"One-year follow-up after multimodal inpatient treatment for cocaine and methamphetamine dependencies.","volume":"9","year":"1992","journal-title":"J Subst Abuse Treat"},{"key":"R182-2-20210129","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0740-5472(02)00256-8","article-title":"Treatment of methamphetamine use disorders: an update.","volume":"23","author":"Rawson R A, Gonzales","year":"2002","journal-title":"J Subst Abuse Treat"},{"key":"R183-2-20210129","first-page":"41","article-title":"Integrating treatments for methamphetamine abuse: a psychosocial perspective.","volume":"16","author":"Huber","year":"1997","journal-title":"J Addict Dis"},{"key":"R185-2-20210129","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1300\/J069v13n04_08","article-title":"P, Newmeyer J, Knapp T, Stalcup S A, Smith D. Imipramine for the treatment of cocaine and methamphetamine dependence.","volume":"13","author":"Galloway","year":"1994","journal-title":"J Addict Dis"},{"key":"R186-2-20210129","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0740-5472(96)00154-7","article-title":"P, Newmeyer J, Knapp T, Stalcup S A, Smith D. A controlled trial of imipramine for the treatment of methamphetamine dependence.","volume":"13","author":"Galloway","year":"1996","journal-title":"J Subst Abuse Treat"},{"key":"R187-2-20210129","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1300\/J069v13n04_02","article-title":"A, McCann M J, Obert J L. The Matrix model of outpatient stimulant abuse treatment: evidence of efficacy.","volume":"13","author":"Shoptaw","year":"1994","journal-title":"J Addict Dis"},{"key":"R188-2-20210129","first-page":"235","article-title":"Fluoxetine and methamphetamine dependencea controlled trial: preliminary analysis.","volume":"180","author":"Batki","year":"1999","journal-title":"NIDA Res Monogr"},{"key":"R189-2-20210129","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s002130051007","article-title":"A, Roache J D, Bordnick P S, Ait-Daoud N. Isradipine, a dihydropyridine-class calcium channel antagonist, attenuates some of d-methamphetamines positive subjective effects: a preliminary study.","volume":"144","author":"Johnson","year":"1999","journal-title":"Psychopharmacology"},{"key":"R190-2-20210129","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/syn.10278","article-title":"D, Figueroa E, Dewey S L. Treating cocaine addiction: from preclinical to clinical trial experience with gamma-vinyl GABA.","volume":"50","author":"Brodie","year":"2003","journal-title":"Synapse"},{"key":"R191-2-20210129","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/syn.20097","article-title":"D, Figueroa E, Laska E M, Dewey S L. Safety and efficacy of gamma-vinyl GABA (GVG) for the treatment of methamphetamine andor cocaine addiction.","volume":"55","author":"Brodie","year":"2005","journal-title":"Synapse"},{"key":"R192-2-20210129","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00008877-199203010-00004","article-title":"Sertindole and several antipsychotic drugs differentially inhibit the discriminative stimulus effects of amphetamine, LSD and St 587 in rats.","volume":"3","author":"Arnt","year":"1992","journal-title":"Behav Pharmacol"},{"key":"R193-2-20210129","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF02245611","article-title":"Inhibitory effects on the discriminative stimulus properties of D-amphetamine by classical and newer antipsychotics do not correlate with antipsychotic activity. Relation to effects on the reward system?","volume":"124","author":"Arnt","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"R194-2-20210129","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0091-3057(02)00766-9","article-title":"A, Wasielewski J A, Carl K L, Holloway F A. Attenuation of the amphetamine discriminative cue in rats with the atypical antipsychotic olanzapine.","volume":"72","author":"Mechanic","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"R195-2-20210129","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1124\/jpet.102.048439","article-title":"R, Stoops W W, Hays L R, Glaser P E, Hays L S. Risperidone attenuates the discriminative-stimulus effects of d-amphetamine in humans.","volume":"306","author":"Rush","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"R196-2-20210129","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0165-1781(01)00255-4","article-title":"F, Ling W, Kalechstein A D, Uslaner J, Tervo K. Risperidone pre-treatment reduces the euphoric effects of experimentally administered cocaine.","volume":"102","author":"Newton","year":"2001","journal-title":"Psychiatry Res"},{"key":"R198-2-20210129","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1176\/appi.ajp.159.6.1018","article-title":"M, Goldman R S, Volavka J, et al. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder.","volume":"159","author":"Bilder","year":"2002","journal-title":"Am J Psychiatry"},{"key":"R199-2-20210129","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/sj.npp.1300216","article-title":"W, Goldberg T E, Marenco S, Bigelow L B, Egan M F, Weinberger D R. Comparison of cognitive performances during a placebo period and an atypical antipsychotic treatment period in schizophrenia: critical examination of confounds.","volume":"28","author":"Weickert","year":"2003","journal-title":"Neuropsychopharmacology"}],"container-title":["Harvard Review of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00023727-200505000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T06:22:18Z","timestamp":1735971738000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00023727-200505000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":169,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1080\/10673220591003605","relation":{},"ISSN":["1067-3229"],"issn-type":[{"value":"1067-3229","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}